Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Am J Perinatol. 2021 Nov 16;40(14):1585–1589. doi: 10.1055/s-0041-1739354

Fig. 2. 17-OHPC concentration is associated with an increased change in IL-10 production in response to LPS.

Fig. 2

Posttreatment (25–28 weeks) and baseline IL-10 production were used to determine the percent change in IL-10 production in response to LPS after initiation of 17-OHPC. The change in IL-10 was then compared by 17-OHPC quartiles and was increased in women with higher quartiles (2–4) of 17-OHPC plasma concentrations. IL-10, interleukin-10; LPS, lipopolysaccharide; 17-OHPC, 17α-hydroxyprogesterone caproate.